NCT06760871

Brief Summary

The aim of this study was to determine the effect of cold vapour applied to patients undergoing laparoscopic abdominal surgery primarily on nausea and vomiting and secondarily on antiemetic requirement, patient satisfaction and thirst. H1: Cold steam application after surgical intervention has a decreasing effect on postoperative nausea. H2: Cold steam application after surgical intervention has a decreasing effect on postoperative vomiting. H3: Cold steam application after surgical intervention reduces the need for antiemetic drugs. H4: Cold steam application after surgical intervention has a satisfactory effect on reducing nausea and vomiting.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 7, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2025

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

January 7, 2025

Status Verified

January 1, 2025

Enrollment Period

3 months

First QC Date

December 17, 2024

Last Update Submit

January 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • nausea rate

    Nausea rate (%)

    6 months

Secondary Outcomes (1)

  • Antiemetic requirement

    6 months

Study Arms (2)

Experimental group

EXPERIMENTAL

Patients in the experimental group will receive inhaled cold vapour.

Other: nebulised distilled water

Control group

NO INTERVENTION

Patients in the control group will not be intervened within the scope of the study.

Interventions

After the surgery, the patients will be admitted to the ward and taken to the bed, and their care and treatment will be applied by the nurse. Afterwards, the researcher will apply cold vapour as an inhaler for 15 minutes. For this application, the stand to which the ultrasonic nebuliser device is connected will be positioned close to the patient's bed. 200 ml of distilled water will be placed in the liquid reservoir of the device. The patient will be given a comfortable position and the device will be adjusted so that the steam hose covers the patient's mouth and nose and the patient will be allowed to inhale the steam through the mouth and nose. After the electrical connection of the device is provided, the device will be started and cold steam application will begin. In the 1st hour, inhaler cold water vapour application will be performed for 15 minutes.

Experimental group

Eligibility Criteria

Age18 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing abdominal surgery under general anaesthesia,
  • Admitted to the general surgery ward after surgery,
  • Who volunteered to participate in the research,
  • No mental disability,
  • years of age,
  • Literate,
  • Accepting random selection,
  • without Turkish communication problems,
  • No preoperative oncological treatment,
  • undergoing elective surgery,
  • Postoperatively without a nasogastric catheter,
  • with an operation time \<4 hours,
  • Laparoscopic surgery performed,
  • No postoperative nausea and vomiting or mild/moderate nausea,

You may not qualify if:

  • Severe nausea or active vomiting prior to administration,
  • Migraine, vertigo, etc. who may experience nausea and vomiting due to vestibular disease, pregnancy,
  • COPD, asthma, etc. with respiratory problems,
  • Not accepting the application of cold steam,
  • Not accepting random selection,
  • Those with a history of chemotherapy or radiotherapy before surgery,
  • Patients who underwent sudden movement changes (bed change, patient transfer, etc.) during the data collection period (0 to 2nd hour),

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Trakya University Hospital

Edirne, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Postoperative Nausea and Vomiting

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomiting

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Patients in the experimental group will receive inhaled cold vapour. Patients in the control group will not be intervened within the scope of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate professor

Study Record Dates

First Submitted

December 17, 2024

First Posted

January 7, 2025

Study Start

January 15, 2025

Primary Completion

April 15, 2025

Study Completion

December 30, 2025

Last Updated

January 7, 2025

Record last verified: 2025-01

Locations